 | | Cardiovascular Exchange Summit 2011 |
|  | | Association of hypertension with absolute and relative risk of stroke and MI |
|
 | | Benefits of antihypertensive treatment is proportional to reduction in blood pressure |
|  | | Benefits of antihypertensive treatment is proportional to reduction in blood pressure |
|
 | | Deciles of Blood Pressure |
|  | | Deciles of Blood Pressure Variability |
|
 | | Patients with episodic hypertension have a high risk of stroke |
|  | | Dia 8 |
|
 | | ACE-I or ARB beneficial in normotensive atherosclerotic patients |
|  | | Care pathway |
|
 | | Care pathway |
|  | | Care pathway |
|
 | | Genetic variants in novel pathways influence blood pressure and cardiovascular disease |
|  | | Normal Pressure |
|
 | | High Pressure due to Constriction |
|  | | High PressureDue to Increased Volume |
|
 | | Evidence for two types of hypertension and response to drugs |
|  | | Comparison of four classes of antihypertensive treatments |
|
 | | Correlations between drug pairs |
|  | | Two types of hypertension:Type 1 (high-renin, vasoconstrictor) |
|
 | | Two types of drugs for hypertension:Type 1(‘AB’ drugs) |
|  | | Two types of drugs for hypertension:Type 1(‘AB’ drugs) |
|
 | | Two types of hypertension:Type 2 (low-renin, Na+ dependent) |
|  | | Two types of hypertension:Type 2 (low-renin, Na+ dependent) |
|
 | | Two types of drugs for hypertension:Type 2 (‘CD’ drugs) |
|  | | AB/CD Rule for optimisation of antihypertensive treatment |
|
|  | | Rationale for study |
|
 | | Effect of Dose and Combination of Antihypertensives on Interindividual Blood Pressure Variability |
|  | | Rationale for study |
|
 | | Rationale for study |
|  | | Rationale for study |
|
|  | | Cambridge ‘abD’ guideline |
|
 | | Spironolactone as 4th line treatment in ASCOT |
|  | | Slaying medical myths: Low-dose thiazides are not maximal |
|
 | | Double-blind, dose-ranging crossover comparison of diuretics in low-renin hypertension |
|  | | Crossover comparison of glucose tolerance on amiloride and HCTZ |
|
 | | The choice of diuretic in hypertension |
|  | | Summary |
|
Deel deze pagina met collega's en vrienden: